日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial.

针对补体因子 H 的抗体 GT103 在难治性非小细胞肺癌中的应用:一项 1b 期剂量递增试验

Clarke Jeffrey M, Simon George R, Mamdani Hirva, Gu Lin, Herndon James E 2nd, Stinchcombe Thomas E, Ready Neal, Crawford Jeffrey, Sonpavde Guru, Balevic Stephen, Nixon Andrew B, Campa Michael, Gottlin Elizabeth B, Li Huihua, Saxena Ruchi, He You Wen, Antonia Scott, Patz Edward F Jr

Complement factor H: a novel innate immune checkpoint in cancer immunotherapy

补体因子H:癌症免疫疗法中的一种新型先天免疫检查点

Saxena, Ruchi; Gottlin, Elizabeth B; Campa, Michael J; Bushey, Ryan T; Guo, Jian; Patz, Edward F Jr; He, You-Wen

Prognostic significance of a complement factor H autoantibody in early stage NSCLC

补体因子H自身抗体在早期非小细胞肺癌中的预后意义

Gottlin, Elizabeth B; Campa, Michael J; Gandhi, Rikesh; Bushey, Ryan T; Herndon Nd, James E; Patz, Edward F Jr

Genetic Variants of CLPP and M1AP Are Associated With Risk of Non-Small Cell Lung Cancer

CLPP和M1AP的基因变异与非小细胞肺癌的风险相关

Li, Xianghan; Zou, Yiran; Li, Teng; Wong, Thomas K F; Bushey, Ryan T; Campa, Michael J; Gottlin, Elizabeth B; Liu, Hongliang; Wei, Qingyi; Rodrigo, Allen; Patz, Edward F Jr

Whole Exome Sequencing of Cell-Free DNA for Early Lung Cancer: A Pilot Study to Differentiate Benign From Malignant CT-Detected Pulmonary Lesions

利用游离DNA进行全外显子组测序以早期诊断肺癌:一项区分CT检测到的良恶性肺部病变的初步研究

Tailor, Tina D; Rao, Xiayu; Campa, Michael J; Wang, Jing; Gregory, Simon G; Patz, Edward F Jr